@Accor on est à l’hôtel F1 Charles de Gaulle et l’informatique est en panne - personne vient à la rescousse du pauvre intérimaire qui n’a pas des bons codes pour redémarrer l’ordinateur. Résultat on est 15 clients qui n’ont pas une chambre à 22h00… qui peut aider??? Rapidement!
Not on our watch !
Today, dying during your #chemo because of the wrong dosage is still possible... but at ODPM we are fighting against this nonsense !
We provide solutions to help patients and oncologists throughout the treatment process.
#cancer
📅Today is the National Adverse Drug Event Awareness Day
This day will shine a light on the 4th leading cause of death in America, adverse drug events!
#health#5FU#fourthcause
😲 How is it possible that while almost all of respondents would adjust the dosage for known DPD-deficient patients, only 20% have ever ordered the test for their patients?!?
#DPDdeficiency#DPYD#oncology
https://t.co/fow2j6QH6W
🛑 Fewer late-stage breast cancer diagnosed in 2020!
"1.9% of patients were diagnosed with stage IV breast cancer in 2019 compared to 6.2% in 2020".
Do not delay your routine healthcare, such as screenings or doctor visits.
https://t.co/X0yFJfHqWQ
#5FU#capecitabine ✅ Dose adjustment is possible and effective!
As the authors note, we have demonstrated that patients with a dosage based on morphology were either over-dosed or under-dosed!
How to adjust the dosage precisely ?
With ODPM ProtocolTM
https://t.co/4Y5sAe0bQP
🎬 ACTION #MEDICA21
Thanks so very much @businessfrance team for this great video!
Our President & Co-founder, @MicheleBoisdron, was there to meet our future collaborators, distributors and partners who were there looking for innovative solutions.
https://t.co/PhRjiICDue
Weight loss tied to 46% reduction in risk of colorectal cancer !
“Our study is the first to investigate weight loss in adulthood in relation to the risk of colorectal adenoma.” Dr. Hughes Barry
https://t.co/2KnWjapON9
March is coming... and it's the European Colorectal Cancer Awareness Month #ECCAM2022.
SAVE THE DATE ! February 23, 11:30 am CET
The event will include expert speakers and policy makers presenting and discussing effective colorectal cancer prevention. https://t.co/3MThdItp3P
Can we anticipate our future diseases thanks to predictive medicine?
✅ Some cancers such as breast cancer are sometimes hereditary. Knowing that you carry one of these genes allows for much better screening.
At ODPM, we are very sensitive to predictive and personalized medicine
#WorldCancerDay is a powerful opportunity to speak out, to call for action and to listen !
Our fight is to include personalized medicIne in the standard cancer care !
#CloseTheCareGap
💬 Why is 5-FU ODPM Protocol™ a personalized medicine solution?
It allows cancer specialists to individually tailor IV 5FU chemotherapy.
What's in it for my patients?
👉 Precise dosage of #5FU | Better treatment efficacy | Avoid toxicities | Improve the quality of life
❌It's time to stop endangering lives!
""The NCCN Guidelines for Colon Cancer acknowledge that pre-treatment DPYD testing has been demonstrated to reduce toxicity and be cost effective.""
🇺🇸 In the US, pre-treatment testing has not been recommended by the FDA or by the NCCN!
@drlw2309 This is such important work. The EMA did a terrific job with their review of DPD deficiency testing and we are all glad they recommended testing, but as your work shows, DPYD is not the full answer. I'd be happy to share our solution with you!
Solutions exist to saves lives!
✅ DPD deficiency tests are cost effective and efficient.
🔬 With a simple test, you can avoid terrible adverse reactions, which can even be fatal. https://t.co/mxaacsYUu9
👍 We agree ! And congratulations to Emma Hulshof, and all for their article in the European Journal of Cancer showing that upfront genotyping of UGT1A1 before #irinotecan#chemotherapy is not only effective in reducing toxicities.
https://t.co/SXgzmc8IrF
⚠️ Did you know ?
In France, certified software for prescribing or dispensing assistance must now include a warning message reminding doctors and pharmacists that the search for a possible deficiency in DPD is mandatory to allow the initiation of treatment with fluoropyrimidines
🔥 Thank you 2021, but...2022 is the year of innovative projects for us!
Expanding our product line and our export pipeline!
We wish all of you a wonderful 2022, full of good things-health, prosperity and success!